Joshua Stern, MD
Urology · Stoneham, MANPI 1174727960
Payments from drug & device makers
Across 19 payments — averaging $206.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Laborie Medical Technologies Corp.$193
- Boston Scientific$129
- Olympus America Inc.$112
- 180 Medical, Inc.$111
- Medtronic$104
- plus $271 from 7 others
Across 1 payment — averaging $352.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Urogen Pharma, Inc.$352
What the payments were for
- Food & beverage$92023%
- Education$3,00077%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 1 | $3,000 |
| Laborie Medical Technologies Corp. | 2 | $193 |
| Boston Scientific | 3 | $129 |
| Olympus America Inc. | 3 | $112 |
| 180 Medical, Inc. | 1 | $111 |
| Medtronic | 1 | $104 |
| Ambu Inc. | 1 | $96 |
| Procept Biorobotics Corporation | 2 | $56 |
| Axonics, Inc. | 1 | $31 |
| Covidien LP | 1 | $27 |
| Johnson & Johnson | 1 | $26 |
| Myriad Genetic Laboratories, Inc. | 1 | $20 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,920 in reported general payments places this provider in the 65th percentile of 327 urology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 28 | $25,332 |
| Tamsulosin Hcl | 217 | $2,888 |
| Finasteride | 190 | $2,559 |
| Potassium Citrate ErPotassium Citrate | 18 | $2,061 |
| Solifenacin Succinate | 63 | $1,180 |
| Trospium Chloride | 13 | $427 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 48 | $405 |
| Imipramine Hcl | 11 | $175 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 57 | $131 |
Paid to pharmacies, not to this prescriber.
Other urology in Stoneham
- Christopher CutieBoston$3.5M
- Henry MitchesonWatertown$1.6M
- Brian EisnerBoston$1.4M
- Mark PrestonBoston$1.2M
- David StaskinBrighton$807K
- Abraham MorgentalerChestnut Hill$522K
- Alejandro SanchezBoston$349K
- Liam HurleyNorth Andover$319K
- Adam KibelBoston$316K
- Tony LuongoBoston$303K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.